IL-4 and IL-13, as key type-2 inflammatory cytokines, could disrupt the barrier function of epithelial cells, leading to accumulation of cellular matrix proteins and EMT progress, and consequently participate in airway remodeling in asthma [3–5]. This evidence concerns the gene IL13 and asthma.